In this report, the Endoscopic Ultrasound Needles Market has been segmented by Product, Material, Application, End Users and Geography.

Endoscopic Ultrasound Needles Market, Segmentation by Product

The Endoscopic Ultrasound Needles Market has been segmented by Product into Aspiration Needles (EUS-FNA) and Biopsy Needles (EUS-FNB).

Global Endoscopic Ultrasound Needles Market, Segmentation by Material

The Global Endoscopic Ultrasound Needles Market has been segmented by Material into Stainless Steel, Plastic, and Composite Materials.

Stainless Steel
Stainless steel EUS needles dominate the market, making up about 68% of global usage. Renowned for their precision, durability, and consistent performance, stainless steel needles are widely used in cytological and histological procedures. Their rigid design allows for accurate targeting, especially in deep or hard-to-reach lesions, and ensures minimal distortion during biopsy. Most hospital-grade FNA and FNB systems rely on stainless steel construction.

Plastic
Plastic-based EUS needles represent around 17% of the market and are favored for their lightweight structure, cost-effectiveness, and flexibility. Though less robust than metallic counterparts, plastic needles are used in non-complex diagnostic procedures, training settings, and in clinics seeking low-cost alternatives. They are also suitable for cases where reduced rigidity is clinically advantageous.

Composite Materials
Composite EUS needles, comprising roughly 15% of the market, blend metallic cores with polymeric exteriors to provide enhanced tactile control, biomechanical flexibility, and less tissue disruption. These materials are increasingly adopted in advanced therapeutic endoscopy, where the balance between steerability and puncture accuracy is crucial—especially in pancreatic and submucosal lesions.

Global Endoscopic Ultrasound Needles Market, Segmentation by Application

The Global Endoscopic Ultrasound Needles Market has been segmented by Application into Bronchial Needles and Enteral Needles.

Bronchial Needles
Bronchial EUS needles hold a market share of around 58%, driven by their critical role in endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). These needles are used to diagnose and stage lung cancer, sarcoidosis, and mediastinal infections by sampling lymph nodes and peribronchial masses. With increasing reliance on minimally invasive diagnostic tools in pulmonology, bronchial needles are essential for improving respiratory disease outcomes.

Enteral Needles
Enteral EUS needles represent approximately 42% of the global market and are widely used in gastrointestinal endoscopy to obtain tissue from pancreatic cysts, gastric wall lesions, submucosal tumors, and nearby organs such as the liver and adrenal glands. As EUS-guided biopsy and aspiration become standard in GI oncology and interventional gastroenterology, the demand for precision enteral needles continues to grow.

Global Endoscopic Ultrasound Needles Market, Segmentation by End Users

The Global Endoscopic Ultrasound Needles Market has been segmented by End Users into Hospitals, Ambulatory Surgical Centers and Specialty Clinics.

Hospitals
Hospitals hold the largest share of the global endoscopic ultrasound needles market at approximately 61%. Their access to comprehensive diagnostic imaging, interventional teams, and anesthesia support enables them to manage complex cases, including lung cancer staging, pancreatic biopsies, and gastrointestinal tumor evaluation. Hospitals remain the primary setting for high-volume EUS-guided procedures, especially in tertiary and academic centers.

Ambulatory Surgical Centers (ASCs)
Ambulatory surgical centers (ASCs) represent about 23% of the market and are becoming integral to the delivery of minimally invasive diagnostics. These centers focus on day-case procedures, leveraging streamlined workflows and cost-effective technologies to offer EUS-guided aspirations and biopsies. ASCs are expanding rapidly, especially in developed regions, where outpatient GI and pulmonary services are in high demand.

Specialty Clinics
Specialty clinics, including gastroenterology and pulmonology practices, make up around 16% of global EUS needle usage. These clinics are optimizing diagnostic care by offering on-site EUS procedures, supported by compact ultrasound equipment and office-based procedural rooms. As the trend toward localized, outpatient-focused diagnostics grows, these clinics are emerging as important users of EUS-FNA and EUS-FNB devices.

Global Endoscopic Ultrasound Needles Market Share (%), by Geographical Region, 2024

North America
North America dominates the global endoscopic ultrasound needles market, capturing about 41% of the total share. This leadership is driven by the region’s robust healthcare ecosystem, frequent use of EUS-FNA and FNB in oncology, and extensive availability of trained specialists. The U.S. in particular benefits from early technology adoption, well-established GI diagnostic pathways, and insurance coverage for EUS-guided procedures.

Europe
Europe contributes nearly 26% of the global market. The region's growth is supported by comprehensive screening programs, widespread use of minimally invasive diagnostics, and high procedural volumes in countries like Germany, France, and the UK. Ongoing advancements in biopsy techniques and increasing demand for histology-based diagnosis are enhancing FNB needle usage.

Asia Pacific
Asia Pacific, holding around 22%, is the fastest-expanding regional market. The increasing incidence of gastrointestinal and pancreatic cancers, coupled with improved access to advanced endoscopy, is fueling regional demand. Key markets such as India, China, and Japan are also investing in endoscopic training, cancer awareness, and hospital modernization, supporting widespread EUS adoption.

Middle East & Africa
Middle East & Africa account for approximately 6% of the global market. The region is seeing growth in oncology diagnostics and interventional pulmonology, especially in countries like Saudi Arabia and the UAE. Healthcare reforms and investments in specialty hospitals are enhancing access to EUS-based diagnostic solutions, though rural access remains limited.

Latin America
Latin America represents about 5% of the market. Brazil and Mexico are leading efforts to expand GI endoscopy infrastructure and support early detection of cancer. While urban centers are seeing adoption of EUS-guided needle technologies, growth is hindered in some areas by cost barriers and uneven distribution of trained specialists.